Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by Boomskidon Jan 16, 2023 10:12am
110 Views
Post# 35225450

RE:Lessons learned:

RE:Lessons learned:There's a lot left out of poof's story, stuff that he couldn't be expected to know. Some of it is rather bizarre and maybe it can be discussed or revealed someday. I can't reveal it.

More important than capitalizing a company with loans and equity financings is a notion that has been foreign to Bioasis - DOING SOME BUSINESS!

Deals!

The question is whether there were deals to be done that were purposely postponed or otherwise avoided in favour of giving up on Bioasis and doing this awful sellout.

If the true value of a successful xB3 is eventually expressed in other hands, the magnitude of Bioasis mangements' failures will be documented beyond all doubt.

After almost 15 years, the last capitalizations by equity financings and loans should have been a long time ago and deals should now be making the company and its shareholders wealthy.

To poof, I say, don't bother telling us what we already know. Help us find out what happened. 

jd
<< Previous
Bullboard Posts
Next >>